NewGenIVF Group Limited (NIVF) experienced a dramatic surge in its stock price on Thursday, climbing approximately 61% to $1.19 in heavy Nasdaq trading. The Bangkok-based company announced a strategic investment in K25.ai, an Asia-focused AI live-streaming prediction-market platform, sending shares to an intraday high of $1.50.
The move represents a significant pivot for NewGenIVF, which has been moving away from its original fertility-services focus amid financial challenges. The company's 2025 annual report revealed declining revenue of $4.73 million, down from $5.43 million the previous year, and cash reserves of just $758,621, raising going-concern warnings.
Investment Details
According to a 6-K filing with the SEC, NewGenIVF agreed to purchase an initial 2% stake in PredicXion Group, operating as K25.ai, at a $100 million pre-money valuation. The consideration includes $1 million in cash, stablecoin, or Solana, plus 666,667 newly issued NewGenIVF Class A shares priced at $1.50 each. The company also holds an option to increase its ownership to 10% for an additional $4 million in cash or crypto and $4 million in shares.
The transaction remains subject to due diligence, definitive documentation, regulatory approvals, and other closing conditions, as noted in the filing.
Market Context
The rally reflects investor enthusiasm for artificial intelligence and prediction markets, even in small-cap names. Prediction markets allow users to trade contracts tied to future events, with prices signaling perceived probabilities. The sector is becoming increasingly competitive, with established players like Polymarket and Kalshi, the latter having recently partnered with the NHL under an information-sharing agreement with the U.S. Commodity Futures Trading Commission.
NewGenIVF CEO Alfred Siu Wing Fung described the investment as providing exposure to the convergence of AI, live streaming, and creator monetization. K25.ai founder Andy Cheung, a former OKX chief operating officer, characterized the platform as a new generation of interactive markets.
Governance and Expansion Plans
The agreement includes governance provisions: PredicXion may nominate three independent non-executive directors to NewGenIVF's board post-closing, while NewGenIVF would receive a non-voting observer seat on PredicXion's board. Additionally, NewGenIVF will serve as exclusive agent for K25.ai in Thailand, Singapore, Japan, and other agreed APAC territories (excluding Hong Kong), earning a 10% commission on gross profit from introduced customers.
Risks and Volatility
Despite the surge, significant risks remain. The deal has yet to close, K25.ai's products are restricted to legally permitted markets, and NewGenIVF faces potential dilution from equity lines, warrants, and convertible notes. The stock has a history of volatility, with Nasdaq mandating a one-for-four reverse stock split in March, following several earlier splits.
The broader market context was mixed, with Wall Street indexes lower as oil prices and Treasury yields rose. Art Hogan of B Riley Wealth noted fading optimism over Iran talks contributed to the downturn.
For now, NewGenIVF's rally is driven more by optionality than fundamentals, as investors bet on AI and prediction market exposure without confirmed revenue from K25.ai.
